Journals / İstanbul Kanuni Sultan Süleyman Tıp Dergisi / 2021 / Cilt: 13 - Sayı: 1

Subtypes and Outcomes of Childhood Guillain-Barré Syndrome: A Single Center Experience

Çocukluk Çağı Guillain-Barré Sendromunun ID Alt Tipleri ve Sonuçları: Tek Merkez Deneyimi

Pages
47–54
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The prognosis was found to be significantly different between electrophysiological subtypes in our series, axonal forms being consistent with poor prognosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study, we aimed to revise the clinical, epidemiologic and prognostic features of childhood Guillain-Barré syndrome.
📊
Key Findings & Data:Method: Thirty two children admitted to our hospital and diagnosed with Guillain-Barré syndrome between June 2007- November 2019 were enrolled in the study.
💡
Conclusion & Impact:The prognosis was found to be significantly different between electrophysiological subtypes in our series, axonal forms being consistent with poor prognosis.
🔬Design:Research Article
📍Scope:2007 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: In this study, we aimed to revise the clinical, epidemiologic and prognostic features of childhood Guillain-Barré syndrome. Method: Thirty two children admitted to our hospital and diagnosed with Guillain-Barré syndrome between June 2007- November 2019 were enrolled in the study. We also administered clinical evaluation scale at onset, discharge, 1,3,6 and 12 months after discharge. Results: The median age was 72.22 months (range from 6 to 202 months) with a male to female ratio of 1.46. Based on electrophysiological features; 22 patients were classified as acute inflammatory demyelinating polyradiculoneuropathy, 10 as acute motor axonal neuropathy. The incidence of cranial nerve involvement was 28.1 % and was related to lower clinical scale score at admission and discharge. Clinical scale scores were significantly different between axonal and demyelinating subgroups except for admission. At 12th month follow-up visit, 78.1% of patients were recovered without sequal. Conclusion: We think that the most important predictor of morbidity is predicting the possible ventilatory support need during the follow up period. Short incubating period of antecedent infection and cranial nerve involvement will probably increase ventilatory support need. The prognosis was found to be significantly different between electrophysiological subtypes in our series, axonal forms being consistent with poor prognosis.

Özet

Amaç: Bu çalışmada çocukluk çağı Guillain-Barré sendromu tanılı hastaların klinik, epidemiyolojikve prognosik özelliklerinin gözden geçirilmesi amaçlanmıştır.Yöntem: Haziran 2007-Kasım 2017 tarihleri arasında hastanemize başvuran Guillain-Barrésendromu tanısı almış 32 çocuk çalışmaya dahil edildi. İlave olarak hastaların başlangıç,taburculuk, 1, 3, 6 ve 12. aylardaki klinik skorları da değerlendirmeye alındı.Bulgular: Ortanca yaş 72.22 ay (min:6 ay max:202 ay) ve erkek kız oranı: 1.46 olarak saptandı.Elektrofizyolojik özelliklere dayanılarak 22 hasta akut inflamatuvar demiyelinizan polinöropati,10 hasta akut motor aksonal nöropati olarak sınıflandı. Kraniyal sinir tutulumu oranı%28.1 idi ve başvuru ve taburculuk sırasında düşük klinik skorlarla ilişkili bulundu.Aksonal ve demiyelinizan formların klinik skorları, başvuru hariç istatistiksel olarak anlamlıfarklılık gösterdi. On ikinci ayda tamamen iyileşenlerin oranı %78.1 bulundu.Sonuç: İzlemde morbidite açısından en önemli belirtecin hastanın olası ventilatör ihtiyacınıöngörmek olduğunu düşünmekteyiz. GBS öncesi geçirilmiş enfeksiyonun inkübasyon süresininkısa olması ve kranial sinir tutulumu hastanın mekanik ventilasyon ihtiyacını arttırabilir.Bizim çalışmamızda elektrofizyolojik alt gruplar arasında prognoz açısından anlamlı farksaptandı ve aksonal form kötü prognozla uyumlu bulundu.

🔖

Cite This Article

TEBER, S., GÖKTAŞ, Ö. A., BEKTAŞ, Ö., YÜKSEL, M. F., ŞAHİN, S. (2022). Subtypes and Outcomes of Childhood Guillain-Barré Syndrome: A Single Center Experience. İstanbul Kanuni Sultan Süleyman Tıp Dergisi, Cilt: 13 - Sayı: 1, 47–54. https://ajindex.com/articles/550914

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Yuki N, Hartung HP. Guillain-Barré syndrome. N Engl J Med. 2012;366:2294-2304.
  2. Govoni V, Granieri E. Epidemiology of the Guillain-Barré syndrome. Cur Opin Neurol. 2001;14:605-13.
  3. Amato AA, Dumitru D. Acquired neuropathies. In: Dumitru D et al., eds. Electrodiagnostic medicine. Philadelphia: Hanley&Belfus, Inc, 2002;937-1041.
  4. Van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol. 2008;7:939-50.
  5. Mcgrogan A, Madle GC, Seaman HE, De Vries CS. The epidemiology of Guillain-Barré syndrome worldwide. Neuroepidemiology. 2009;32:150-63.
  6. Hughes RA, Rees JH. Clinical and epidemiological features of Guillain-Barré syndrome. J Infect Dis. 1997;176:92-8.
  7. Hadden RD, Cornblath DR, Hughes RA, et al. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Ann Neurol. 1998;44(5):780-88.
  8. Ma YM, Liu TK, Wong V. Guillain-Barré syndrome in southern Chinese children: 32 year experience in Hong Kong. Pediatr Int. 2010;52(1):13-9.
  9. Van Doorn PA, Kuitwaard K, Walgaard C, et al. IVIG treatment and prognosis in Guillain-Barré syndrome. J Clin Immunol. 2010;30(1):74-8.
  10. Vucic S, Cairns KD, Black KR, Chong PS, Cros D. Neurophysiologic findings in early acute inflammatory demyelinating polyradiculoneuropathy. Clin Neurophysiol. 2004;115(10):2329-35.
  11. Lin JJ, Hsia SH, Wang HS, et al. Clinical variants of Guillain- Barré syndrome in children. Pediatr Neurol. 2012;47:91-6.
  12. Korinthenberg R, Schessl J, Kirschner J. Clinical presentation and course of childhood Guillain-Barré syndrome: a prospective multicentre study. Neuropediatrics. 2007;38:10-7.
  13. Abd-Allah SA, Jansen PW, Ashwal S, Perkin RM. Intravenous immunoglobulin as therapy for pediatric GuillainBarré syndrome. J Child Neurol. 1997;12:376-80.
  14. Kanra G, Ozon A, Vajsar J, et al